These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 4029015)

  • 21. [A clinical study of bile cultures and antibiotic susceptibility test in the patients with operation on biliary tract].
    Li QW; Ji F
    Zhonghua Wai Ke Za Zhi; 2009 Apr; 47(7):527-9. PubMed ID: 19595212
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Chemotherapy on the biliary tract infections. XIII. Miloxacin, a novel chemotherapeutic agent, its excretion into bile and clinical effect on the biliary tract infections (author's transl)].
    Jpn J Antibiot; 1981 Sep; 34(9):1335-52. PubMed ID: 7328756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The intraperitoneal penetration of temocillin.
    Wise R; Donovan IA; Drumm J; Dyas A; Cross C
    J Antimicrob Chemother; 1983 Jul; 12(1):93-6. PubMed ID: 6619048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic experience with temocillin in peritonitis.
    Pfeiffer M; Fock RR
    Drugs; 1985; 29 Suppl 5():194-6. PubMed ID: 3896740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical experience with cefoperazone in biliary tract infections.
    Mashimo K
    Drugs; 1981; 22 Suppl 1():100-7. PubMed ID: 6456883
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kinetics of mezlocillin in patients with biliary t-tube drainage.
    Gundert-Remy U; Förster D; Schacht P; Weber E
    J Antimicrob Chemother; 1982 Jan; 9 Suppl A():65-75. PubMed ID: 6210684
    [No Abstract]   [Full Text] [Related]  

  • 27. Temocillin in the treatment of gram-negative septicaemia.
    Van Landuyt HW; Lambert A; Van Couter A; Boelaert J
    Drugs; 1985; 29 Suppl 5():182-5. PubMed ID: 3896738
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Concentrations of cefmenoxime and cefotiam in the bile and gallbladder tissue following intravenous administration in patients with biliary tract diseases].
    Shoda Y; Matsuyama S; Takarada A; Arai M; Nagashima K; Nakano G; Nakamura T; Kamisaka K; Matsuzawa T; Yoshino T
    Jpn J Antibiot; 1986 May; 39(5):1259-72. PubMed ID: 3463776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Biliary excretion and clinical evaluation of cefoperazone in the biliary tract infections].
    Koizumi M; Simosegawa T; Yanbe M; Goto Y; Sugawara H; Kanno Y; Kanazawa Y; Kai Y; Sato T; Endou K
    Jpn J Antibiot; 1986 Jul; 39(7):1663-70. PubMed ID: 3773263
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics and tissue penetration of temocillin.
    Lockley MR; Brown RM; Wise R
    Drugs; 1985; 29 Suppl 5():106-8. PubMed ID: 4029011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Temocillin penetration of peripheral lymph.
    Bergan T; Olszewski WL; Engeset A
    Drugs; 1985; 29 Suppl 5():114-7. PubMed ID: 4029013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Chemotherapy of biliary tract infection (35): Biliary excretion of cefteram pivoxil].
    Tanimura H; Nagai Y; Aoki Y; Matsumoto H; Ohtani H; Henmi K; Sawada H; Mukaihara S; Honda K; Kato D
    Nihon Geka Hokan; 1988 Sep; 57(5):400-12. PubMed ID: 3251426
    [No Abstract]   [Full Text] [Related]  

  • 33. Temocillin in the treatment of chest infections.
    Gray JM; Leiper JM; Lawson DH; Cowan W; Baird A; Sleigh JD
    Drugs; 1985; 29 Suppl 5():197-200. PubMed ID: 4029025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection.
    De Jongh R; Hens R; Basma V; Mouton JW; Tulkens PM; Carryn S
    J Antimicrob Chemother; 2008 Feb; 61(2):382-8. PubMed ID: 18070831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human pharmacokinetics and antimicrobial activities of the temocillin epimers.
    Guest EA; Horton R; Mellows G; Slocombe B; Swaisland AJ; Tasker TC; White AR
    Drugs; 1985; 29 Suppl 5():154-61. PubMed ID: 4029021
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Biliary excretion of metampicillin].
    Lande M
    Presse Med (1893); 1970 Apr; 78(17):805-6. PubMed ID: 5439760
    [No Abstract]   [Full Text] [Related]  

  • 37. Temocillin (6 g daily) in critically ill patients: continuous infusion versus three times daily administration.
    Laterre PF; Wittebole X; Van de Velde S; Muller AE; Mouton JW; Carryn S; Tulkens PM; Dugernier T
    J Antimicrob Chemother; 2015 Mar; 70(3):891-8. PubMed ID: 25433006
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lung tissue penetration of temocillin.
    Cowan W; Baird A; Sleigh JD; Gray JM; Leiper JM; Lawson DH
    Drugs; 1985; 29 Suppl 5():151-3. PubMed ID: 4029020
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Temocillin in the treatment of pyelonephritis in children.
    Verboven M; Lauwers S; Pintens H
    Drugs Exp Clin Res; 1987; 13(3):171-3. PubMed ID: 3622246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Chemotherapy of biliary tract infections (XXXVII). Excretion into bile and gallbladder tissue levels of levofloxacin and its clinical effect in biliary tract infections].
    Tanimura H; Ohnishi H; Okamura T; Uenishi M; Ichimiya G; Kobayashi Y; Aoki Y; Oka S; Yamamoto S; Shimada K
    Jpn J Antibiot; 1992 May; 45(5):557-68. PubMed ID: 1512942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.